Associated Papers
Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
Haverfield EV et al.
Bmc Medicine, 2021
34404389 (PubMed )
Supplement: 12916_2021_1999_MOESM2_ESM.pdf
Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas.
Delacruz RGC et al.
Oncotarget, 2019
31231471 (PubMed )
Supplement: oncotarget-10-3939-s001.pdf
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.
Hovelson DH et al.
Oncotarget, 2017
29163793 (PubMed )
Supplement: oncotarget-08-89848-s005.xlsx › TableS4
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.
Andresen PA et al.
Journal of Cancer Research and Clinical Oncology, 2009
Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.
Friedl W et al.
Hereditary Cancer in Clinical Practice, 2005
Select a paper to view details